Related Experiment Video
Updated: Jan 26, 2026
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases
Sruthi Vijaya Retnakumar1, Sylviane Muller2
1CNRS-University of Strasbourg, Biotechnology and Cell signaling, Institut de Science et d'ingénierie Supramoléculaire, 67000 Strasbourg, France.
Abstract:
The arsenal of effective molecules to treat patients with chronic inflammatory bowel diseases (IBDs) remains limited. These remitting-relapsing diseases have become a global health issue and new therapeutic strategies are eagerly awaited to regulate the course of these disorders. Since the association between autophagy-related gene polymorphism and an increased risk of Crohn's disease (CD) has been discovered, a new domain of investigation has emerged, focused on the intracellular degradation system, with the objective of generating new medicines that are safer and more targeted. This review summarizes the drugs administered to IBD patients and describes recently emerged therapeutic agents. We compile evidence on the contribution of autophagy to IBD pathogenesis, give an overview of pharmacological autophagy regulators in animal models of colitis, and propose novel therapeutic avenues based on autophagy components.
Insights
New research explores autophagy
Area of Science:
- Gastroenterology and Immunology
- Cellular Biology
- Drug Discovery
Background:
- Chronic inflammatory bowel diseases (IBDs), including Crohn's disease (CD), have limited treatment options.
- Autophagy, an intracellular degradation process, is increasingly implicated in IBD pathogenesis.
- Genetic links between autophagy-related genes and Crohn's disease risk highlight therapeutic potential.
Purpose of the Study:
- To review current and emerging therapeutic agents for IBD.
- To summarize the role of autophagy in IBD development.
- To explore autophagy modulation as a novel therapeutic strategy for IBD.
Main Methods:
- Comprehensive literature review of IBD treatments.
- Analysis of studies linking autophagy to IBD pathogenesis.
- Examination of pharmacological autophagy regulators in preclinical colitis models.
Main Results:
- Current IBD therapies are limited in efficacy.
- Autophagy plays a significant role in the inflammatory processes of IBD.
- Pharmacological modulation of autophagy shows promise in preclinical models.
Conclusions:
- Targeting autophagy presents a promising new avenue for developing safer and more specific IBD therapies.
- Further research into autophagy regulators could lead to innovative treatments for inflammatory bowel diseases.
- Modulating the autophagy pathway offers a novel strategy to manage IBD course.
More Related Videos
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...